SYDNEY, Australia and WOBURN, Mass., Oct. 25 /PRNewswire-FirstCall/ -- Today Proteome Systems Ltd (ASX: PXL - News) announced exciting results, further supporting its EUK-207 therapeutic development program to prevent acute cognitive impairment occurring during carotid artery bypass graft (CABG) and open heart surgery.
